4//SEC Filing
Tari Leslie 4
Accession 0001209191-22-002600
CIK 0001610618other
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 8:20 PM ET
Size
10.4 KB
Accession
0001209191-22-002600
Insider Transaction Report
Form 4
Tari Leslie
CHIEF SCIENTIFIC OFFICER
Transactions
- Sale
Common Stock
2022-01-05$1.25/sh−1,252$1,565→ 155,400 total - Exercise/Conversion
Restricted Stock Unit
2021-12-29−2,101→ 1,574 totalExp: 2027-09-17→ Common Stock (2,101 underlying) - Exercise/Conversion
Common Stock
2021-12-29+2,101→ 156,652 total
Holdings
- 13,298(indirect: By Spouse)
Common Stock
Footnotes (5)
- [F1]The Reporting Person was previously granted restricted stock units to vest upon the achievement of certain milestone events that occurred on December 29, 2021.
- [F2]Includes 4,000 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on November 19, 2021.
- [F3]Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units on December 29, 2021 and January 1, 2022. These sales are mandated by the Reporting Person's election to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
- [F4]Each restricted stock unit is the economic equivalent of one share of common stock of the Issuer.
- [F5]On January 31, 2019, the Reporting Person was granted restricted stock units totaling 5,250 shares subject to vesting upon the achievement of various milestones.
Documents
Issuer
Cidara Therapeutics, Inc.
CIK 0001610618
Entity typeother
Related Parties
1- filerCIK 0001870270
Filing Metadata
- Form type
- 4
- Filed
- Jan 6, 7:00 PM ET
- Accepted
- Jan 7, 8:20 PM ET
- Size
- 10.4 KB